Innovative Malaria Diagnosis: HIV Rapid Test

Short Description:

HIV (Human immunodeficiency viruses) causes HIV infection and over time acquired immunodefi-ciency syndrome (AIDS). AIDS is a condition in humans in which progressive failure of the immune system allows life-threat-ening opportunistic infections and cancers to thrive.
 

Place of Origin:China
Brand name:TZcheck

Certification:CE


Product Detail

Product Tags

At Tongzhou Biotechnology, we prioritize health, making it our mission to provide reliable, cutting-edge solutions for malaria diagnosis. One of our pioneering products is the HIV Rapid Test, specifically designed and developed for precise malaria diagnosis. This rapid test is a beacon of hope for the global healthcare community, offering an option for quick and accurate diagnosis of malaria. Developed after comprehensive research and clinical trials, our HIV Rapid Test is equipped with advanced technology that makes malaria diagnosis swift, simple, and accurate. It is widely recognized for its high accuracy rates, speed, and ease of use. This test acts as a vital tool in the hands of healthcare professionals worldwide, empowering them to provide timely treatment and potentially save lives.

  1. HIV Rapid Test


  • Cat. No.

    Product Description

    Specimen

    Format

    Kit Size

    I099-3002

    HIV 1.2 Rapid Test

    S / P

    Cassette

    25 T

    I099-4001

    WB/S/P

    Dipstick

    50 T

    I099-4002

    Cassette

    25 T

    I099-4002S

    HIV 1.2 Rapid Test Single Use Kit

    WB

    Cassette

    1 T

    I100-4001

    HIV 1.2.O Rapid Test

    WB/S/P

    Dipstick

    50 T

    I100-4002

    Cassette

    25 T

    I100-4002S

    HIV 1.2.O Rapid Test Single Use Kit

    WB

    1 T

    I101-4002

    HIV p24 Antigen Rapid Test

    WB/S/P

    25 T

    I102-4025

    HIV 1.2 and HIV p24 Combo Rapid Test

    I102-4002

    I147-T4002

    HIV 1.2.O and HIV p24 Combo Rapid Test

    WB/S/P

    Cassette

    25 T

  • HIV continues to be a major global public health issue. HIV/AIDS is considered a pandemic - a

    disease outbreak which is present over a large area and is actively spreading. The African Region is the most affected region, it accounts for almost two thirds of the global total of new HIV infections.

    HIV screening is recommended by the United States Preventive Services Task Force for all people

    15 years to 65 years of age including all pregnant women.

    The latest recommendations of the US Centers for Disease Control and Prevention (CDC) show that HIV testing must start with an immunoassay combination test for HIV-1 and HIV-2 antibodies and p24 antigen.

    HIV 1.2.O

    HIV (Human Immunodeficiency Virus) is the etiologic agent of Acquired Immune Deficiency Syndrome (AIDS). Detection of HIV antibodies in serum, plasma or whole blood is the most efficient and common way to determine whether an individual has been exposed to HIV and to screen blood and blood products for HIV. Despite the differences in their biological characters, serological activities and genome sequences, HIV-1, HIV-2, and Subtype O show strong antigenic cross-reactivity. Most HIV-2 positive sera can be identified by using HIV-1 based serological tests.

    HIV p24

    The HIV p24 antigen is a small piece of protein that is found on the capsule of the HIV virus. When a person is infected with HIV, these bits of protein can be found floating in the blood. The HIV p24 antigen rapid test is the test that detects these bits of protein. The presence of p24 antigen in the blood indicated a recent HIV infection.

    Product Advantages


    -Fast results in 10 minutes

    -Easy visually interpretation

    -High accuracy

    (Sensitivity>99.9%, Specificity>99.8%)



The simplicity and speed of the HIV Rapid Test render it an ideal tool in the fight against malaria, particularly in regions where the disease is prevalent. By accelerating the malaria diagnosis process, healthcare professionals can administer appropriate treatments more rapidly, thus decreasing the risk of complications and improving patient outcomes. The HIV Rapid Test is not only an efficient tool for diagnosing malaria but also a giant leap forward in global health efforts. With this test, we're helping healthcare providers worldwide to enhance their malaria diagnosis capabilities, resulting in improved patient care and health outcomes. At Tongzhou Biotechnology, our commitment to the fight against malaria is unwavering — and our innovative solutions like the HIV Rapid Test are a testament to that dedication. We remain focused on developing forward-thinking healthcare solutions that save lives and contribute to healthier global communities.

  • Previous:
  • Next:
  • Leave Your Message